2018 Kauai

The 6th Annual Molecular Psychiatry Meeting
Kauai, Hawaii, September 27 – 29, 2018

The 6th Annual Molecular Psychiatry Meeting took place in Kauai on September 27 – 29, 2018. All researchers interested in learning about various molecular approaches to enhance understanding of psychiatric disease were invited to attend this open meeting.

Organizing Board:

  • Carrie Bearden
  • Bill Byerley
  • Stephanie Dulawa
  • Rob Malenka
  • Tracey Petryshen
  • Stephan Sanders
  • Akira Sawa
  • Martin Schalling

View Full Schedule

Poster Abstracts

Registration Cost

$600 for investigators before September 1st; $600 afterwards

$300 for students before September 1st; $300 afterwards

Costs of registration includes a one year membership to the Molecular Psychiatry Association.

Location

Hyatt Regency in Maui

200 Nohea Kai Dr, Lahaina, HI 96761
(808) 661-1234

Please note the Hyatt Hotel is sold out.   There are many nearby accommodations at rates similar to the Hyatt in the Kaanapali area.

Click here to visit the Hyatt Regency’s website and book

Plenary Speakers

  • Regulation of Neurotransmitter Receptors in Cognition and Cognitive Disorders, Rick Huganir, John Hopkins School of Medicine
  • Opportunities & challenges in psychiatric neuroscience, Josh Gordon, NIMH

Sessions

  • New Molecular and Circuit-Level Approaches for Understanding the Effects of Chronic Stress in the Mammalian Brain, Stephan Lammel, University of California, Berkeley
  • Utilizing Diversity of Model Organisms for Studying the Molecular Basis of Neuropsychiatric Disorder, Michael Yartsev, University of California, Berkeley
  • The Neural Circuitry Underlying Social Dysfunction, Byungkook Lim, University of California, San Diego
  • Diseases of the Social Brain, Gul Dolen, Johns Hopkins University
  • Calcium Mechanisms in Bipolar Disorder: A Review of Genetic Evidence and Cellular Models, John Nurnberger, Indiana University
  • iPSC-based Platform Development for Major Psychiatric Disorder Modeling and Discovery, Guang Chen, Janssen R&D
  • Molecular Mechanisms of Pain Regulation, Tom Kash, University of North Carolina
  • Building on Advances in Genetics to Validate Novel Molecular Targets for Treatment of Schizophrenia, Jeff Conn, Vanderbilt University
  • Cortico-striatal Circuits in Addiction and Compulsion, Susanne Ahmari, University of Pittsburgh
  • Central and Peripheral Actions of Insulin: Implications for Psychiatric Disorders, Michael McCarthy, University of California, San Diego
  • The Application of Stem Cell Models to Validate Rare and Common Variants Contributing to Schizophrenia and Autism, Mike Talkowski, Massachusetts General Hospital
  • The New Kid on the Block: Glia in Mental and Cognitive Disorders, Misha Pletnikov, Johns Hopkins University
  • Somatic Mosaicism in the Brain: Diverse Neuronal Genomes and Neuropsychiatric Disorders, Alex Urban, Stanford University
  • ISN Symposium Molecular Insights on Organoid and 3D Models to Study Brain Diseases and Development, Chair, Orly Reiner, Weizmann Institute of Science
  • Bridging Molecular Genetics with Population Health to Advance Precision Psychiatry, Lea Davis, Vanderbilt University
  • Molecular Mechanisms of Autism Spectrum Disorders, Brady Maher, Lieber Institute
Back To Top